PCM4EU receives 3M EUR to tailor future cancer treatments to the genetic profile of the tumour.
The original article was published by Leiden University Medical Center (LUMC).
Missed any updates or just exploring? Take a look through our archive!
PCM4EU work package 2's white paper on molecular assays and molecular tumor boards for study inclusion published in JIM.
The PCM4EU Spring Academy took place at IPO Porto, the Portuguese Oncology Institute of Porto on April 2-6.
This video created by the training and education team in PCM4EU, presents the PCM4EU and PRIME-ROSE initiatives.
The Spring Academy takes place at Instituto Português de Oncologia do Porto (IPO Porto) in Porto on April 3-6 2024.
Combining expertise across boarders to implement equitable and sustainable precision cancer medicine
The PCM4EU Spring Academy - Upcoming event in Porto, Portugal, April 2024.
